These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 34512258)

  • 1. Novel Therapies for Parkinsonian Syndromes-Recent Progress and Future Perspectives.
    Przewodowska D; Marzec W; Madetko N
    Front Mol Neurosci; 2021; 14():720220. PubMed ID: 34512258
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetry in Atypical Parkinsonian Syndromes-A Review.
    Chunowski P; Madetko-Alster N; Alster P
    J Clin Med; 2024 Sep; 13(19):. PubMed ID: 39407856
    [No Abstract]   [Full Text] [Related]  

  • 4. The Differential Diagnosis and Treatment of Atypical Parkinsonism.
    Levin J; Kurz A; Arzberger T; Giese A; Höglinger GU
    Dtsch Arztebl Int; 2016 Feb; 113(5):61-9. PubMed ID: 26900156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive supranuclear palsy: A case report and brief review of the literature.
    Batheja V; Fish M; Balar AB; Hogg JP; Lakhani DA; Khan M
    Radiol Case Rep; 2024 Jan; 19(1):250-253. PubMed ID: 38028282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological update: non-motor symptoms in atypical parkinsonian syndromes.
    Ananthavarathan P; Patel B; Peeros S; Obrocki R; Malek N
    J Neurol; 2023 Sep; 270(9):4558-4578. PubMed ID: 37316556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical findings: Atypical parkinsonian syndromes or Atypical parkinsonian syndromes look-alikes.
    Calikusu FZ; Akkus S; Kochan Kizilkilic E; Poyraz BC; Altunç AT; Kiziltan G; Gunduz A
    Clin Neurol Neurosurg; 2023 Oct; 233():107975. PubMed ID: 37734268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.
    Stamelou M; Quinn NP; Bhatia KP
    Mov Disord; 2013 Aug; 28(9):1184-99. PubMed ID: 23720239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
    Fabbrini G; Fabbrini A; Suppa A
    Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis across a cohort of "atypical" atypical and complex parkinsonism.
    Malaquias MJ; Igreja L; Nogueira C; Pereira C; Vilarinho L; Quelhas D; Freixo JP; Oliveira J; Magalhães M
    Parkinsonism Relat Disord; 2023 Jun; 111():105408. PubMed ID: 37105015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of atypical parkinsonian syndromes.
    Lo RY
    Tzu Chi Med J; 2022; 34(2):169-181. PubMed ID: 35465274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Available and future treatments for atypical parkinsonism. A systematic review.
    Moretti DV
    CNS Neurosci Ther; 2019 Feb; 25(2):159-174. PubMed ID: 30294976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences.
    Koziorowski D; Figura M; Milanowski ŁM; Szlufik S; Alster P; Madetko N; Friedman A
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional trials in atypical parkinsonism.
    Eschlböck S; Krismer F; Wenning GK
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S82-92. PubMed ID: 26421389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.